[
  {
    "ts": null,
    "headline": "Thermo Fisher, ICU Medical, CONMED, Pediatrix Medical Group, and IQVIA Stocks Trade Up, What You Need To Know",
    "summary": "A number of stocks jumped in the afternoon session after positive inflation data fueled hopes for an interest rate cut by the Federal Reserve. The latest Consumer Price Index (CPI) report showed inflation rose by a modest 0.2% in July and 2.7% over the last year. This cooler-than-expected data prompted a significant market rally, with the S&P 500, Dow, and Nasdaq all climbing as investors grew more optimistic. The prevailing view is that easing inflation gives the central bank room to lower inte",
    "url": "https://finnhub.io/api/news?id=b1f830d6d11695c97dc4c5eeb0a1165c2ef89ee0a344a116480d00d8ab94c529",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1755022840,
      "headline": "Thermo Fisher, ICU Medical, CONMED, Pediatrix Medical Group, and IQVIA Stocks Trade Up, What You Need To Know",
      "id": 136323044,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "TMO",
      "source": "Yahoo",
      "summary": "A number of stocks jumped in the afternoon session after positive inflation data fueled hopes for an interest rate cut by the Federal Reserve. The latest Consumer Price Index (CPI) report showed inflation rose by a modest 0.2% in July and 2.7% over the last year. This cooler-than-expected data prompted a significant market rally, with the S&P 500, Dow, and Nasdaq all climbing as investors grew more optimistic. The prevailing view is that easing inflation gives the central bank room to lower inte",
      "url": "https://finnhub.io/api/news?id=b1f830d6d11695c97dc4c5eeb0a1165c2ef89ee0a344a116480d00d8ab94c529"
    }
  },
  {
    "ts": null,
    "headline": "Thermo Fisher Scientific (TMO) Oncomine Dx Test Gains FDA Approval for NSCLC Treatment",
    "summary": "Thermo Fisher Scientific (TMO) has seen significant developments with the recent FDA approval of its Oncomine Dx Target Test as a companion diagnostic for HERNEXEOS, contributing to a positive price movement of 7.8% over the last quarter. The approval, alongside the launch of new products and strategic partnerships, positions the company favorably within the precision medicine sector. These advances align with broader market trends, as the S&P 500 and Nasdaq hit all-time highs following...",
    "url": "https://finnhub.io/api/news?id=6177b116a5408481ef47b70c0cf0c8ad2f952f2569a7db0711c8b14ba851be09",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1755019681,
      "headline": "Thermo Fisher Scientific (TMO) Oncomine Dx Test Gains FDA Approval for NSCLC Treatment",
      "id": 136320664,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "TMO",
      "source": "Yahoo",
      "summary": "Thermo Fisher Scientific (TMO) has seen significant developments with the recent FDA approval of its Oncomine Dx Target Test as a companion diagnostic for HERNEXEOS, contributing to a positive price movement of 7.8% over the last quarter. The approval, alongside the launch of new products and strategic partnerships, positions the company favorably within the precision medicine sector. These advances align with broader market trends, as the S&P 500 and Nasdaq hit all-time highs following...",
      "url": "https://finnhub.io/api/news?id=6177b116a5408481ef47b70c0cf0c8ad2f952f2569a7db0711c8b14ba851be09"
    }
  },
  {
    "ts": null,
    "headline": "Thermo Fisher Scientific Inc. stock rises Tuesday, outperforms market",
    "summary": "Thermo Fisher Scientific Inc. stock rises Tuesday, outperforms market",
    "url": "https://finnhub.io/api/news?id=9b73eb9f2c974cc1b311a7f548dcd3321a4444c8270083825164b41f7b0cfac7",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1755016500,
      "headline": "Thermo Fisher Scientific Inc. stock rises Tuesday, outperforms market",
      "id": 136332283,
      "image": "",
      "related": "TMO",
      "source": "MarketWatch",
      "summary": "Thermo Fisher Scientific Inc. stock rises Tuesday, outperforms market",
      "url": "https://finnhub.io/api/news?id=9b73eb9f2c974cc1b311a7f548dcd3321a4444c8270083825164b41f7b0cfac7"
    }
  },
  {
    "ts": null,
    "headline": "FDA approves Thermo Fisher’s diagnostic test for new NSCLC treatment",
    "summary": "In the US, the test has been sanctioned for use with targeted therapies for various cancers.",
    "url": "https://finnhub.io/api/news?id=dbbd743f971f4d149f1846e2a51fd0a836ab25dbcb0efee94df199cea6077d50",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1754994166,
      "headline": "FDA approves Thermo Fisher’s diagnostic test for new NSCLC treatment",
      "id": 136316148,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "TMO",
      "source": "Yahoo",
      "summary": "In the US, the test has been sanctioned for use with targeted therapies for various cancers.",
      "url": "https://finnhub.io/api/news?id=dbbd743f971f4d149f1846e2a51fd0a836ab25dbcb0efee94df199cea6077d50"
    }
  },
  {
    "ts": null,
    "headline": "US Durable Medical Equipment Market Forecast and Competitive Landscape Report 2025-2033 | Invacare, NOVA, Inogen, Thermo Fisher Scientific, Abbott, Medtronic, Baxter, B. Braun, Boston Scientific, BD",
    "summary": "The United States Durable Medical Equipment Market is projected to grow at a CAGR of 5.03% from 2025 to 2033, reaching $97.10 billion by 2033, driven by rising chronic diseases, an aging population, and increased home healthcare demand. Key segments include personal mobility devices and monitoring and therapeutic equipment, with top players like Invacare, Abbott, and Medtronic leading innovations. California and New York are vibrant markets due to their demographics and healthcare infrastructure",
    "url": "https://finnhub.io/api/news?id=1140dfc5dd7cec2d734c3a79338c0bdded44a93ccec66bce7f41a4885c74bde3",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1754988120,
      "headline": "US Durable Medical Equipment Market Forecast and Competitive Landscape Report 2025-2033 | Invacare, NOVA, Inogen, Thermo Fisher Scientific, Abbott, Medtronic, Baxter, B. Braun, Boston Scientific, BD",
      "id": 136316075,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "TMO",
      "source": "Yahoo",
      "summary": "The United States Durable Medical Equipment Market is projected to grow at a CAGR of 5.03% from 2025 to 2033, reaching $97.10 billion by 2033, driven by rising chronic diseases, an aging population, and increased home healthcare demand. Key segments include personal mobility devices and monitoring and therapeutic equipment, with top players like Invacare, Abbott, and Medtronic leading innovations. California and New York are vibrant markets due to their demographics and healthcare infrastructure",
      "url": "https://finnhub.io/api/news?id=1140dfc5dd7cec2d734c3a79338c0bdded44a93ccec66bce7f41a4885c74bde3"
    }
  }
]